A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety
JOURNAL OF CLINICAL PSYCHIATRY, cilt.66, sa.1, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 66 Sayı: 1
- Basım Tarihi: 2005
- Doi Numarası: 10.4088/jcp.v66n0109
- Dergi Adı: JOURNAL OF CLINICAL PSYCHIATRY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Sayfa Sayıları: ss.63-72
- Dokuz Eylül Üniversitesi Adresli: Evet
Özet
Background: Several open trials and case studies have reported beneficial effects following the addition of risperidone for partial responders to clozapine. The purpose of this study was to carry out a placebo-controlled, randomized. double-blind trial of the efficacy, safety, and tolerability of adjunctive treatment with risperidone in patients with schizophrenia partially responsive to clozapine.